
---
title: '新冠药物、新冠检测板块继续回调'
categories: 
 - 新媒体
 - 36kr
 - 快讯
headimg: 'https://picsum.photos/400/300?random=6523'
author: 36kr
comments: false
date: Tue, 25 Jan 2022 03:28:18 GMT
thumbnail: 'https://picsum.photos/400/300?random=6523'
---

<div>   
36氪获悉，新冠药物、新冠检测板块继续回调，截至发稿，精华制药、尖峰集团跌停，富祥药业、翰宇药业跌超10%，兰卫医学、上海凯宝、西陇科学、睿智医药跌逾6%。  
</div>
            